GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
779
c/cagrilintide·posted 18 days ago by u/egfr_watcher

[Trial Data] nausea rates in the combination arm vs sema alone

Trial Data Slow Clap ×9

Right, the amylin question again, but with numbers this time.

I have 11 data points over 10 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 26, not week 75. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

846 up / 67 down93% upvoted27 commentsid ezmiah11 Jul 2026

27 comments

23 in this archive, depth 5

best — the order this archive was captured in

u/hub_opssite staff47 points·16 days ago

REDEFINE which arm?

replysharereportpermalink
u/plain_titration41 points·17 days ago

The research community is small on cagrilintide. Forum lore changes faster than data.

replysharereportpermalink
u/sanne_laurent10 points·17 days ago

Disagree but this is the good kind of wrong — it is specific enough to be checked.

replysharereportpermalink
u/laila_dumitru20 points·17 days ago

CagriSema is a fixed combo in trials, not user-mixed

replysharereportpermalink
u/noor_hovland6 points·17 days ago

This is correct. The co-agonism is real.

replysharereportpermalink
u/rekha_mwangi5 points·17 days ago

REDEFINE readouts are phase 6 data

replysharereportpermalink
u/helga_vermeulen3 points·17 days ago

tendon and CagriSema literature in rodents is interesting

replysharereportpermalink
u/amylin_amyamylin22 points·17 days ago

long-acting amylin is co-agonism, different satiety profile

replysharereportpermalink
u/ledger_modMOD13 points·17 days ago

Removed a chain here. The rule is one line long and it is not negotiable.

replysharereportpermalink
u/egfr_watcherOP5 points·17 days ago

REDEFINE phase 21 readouts are interesting but 21 person REDEFINE is different from 21 trial REDEFINE.

replysharereportpermalink
[removed]4 points·17 days ago

[removed by moderator]

replysharereportpermalink
u/ice_pack_auditcold chain6 points·16 days ago

the mechanism is different, the side effect profile reflects it

replysharereportpermalink
u/egfr_watcher7 points·17 days ago

This is correct. The co-agonism is real.

replysharereportpermalink
u/amara_halonen5 points·16 days ago

long-acting amylin is CagriSema, different satiety profile

replysharereportpermalink
u/egfr_watcherOP2 points·16 days ago

long-acting amylin is CagriSema, different satiety profile

Adding to this: amylin is doing more work than the comment implies.

replysharereportpermalink
u/yara_mensah17 points·17 days ago

This is correct. The co-agonism is real.

replysharereportpermalink
u/forest_plot_fionastats12 points·18 days ago

CagriSema ratios in trials are fixed, do not extrapolate self-mixing

replysharereportpermalink
u/egfr_watcherOP9 points·17 days ago

The research community is small on cagrilintide. Forum lore changes faster than data.

replysharereportpermalink
u/sten_rautio13 points·17 days ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/ines_ekstrom0 points·17 days ago

long-acting amylin is CagriSema, different satiety profile

replysharereportpermalink
u/zeynep_ndiaye6 points·17 days ago

Strongly agree. REDEFINE is phase 7, not final.

replysharereportpermalink
u/noor_vermeulen-28 points·17 days ago

Yeah, amylin is doing different work than GLP-1.

replysharereportpermalink
load more comments (1) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.